Overview
Diffuse palmoplantar keratoderma, Bothnian type (also known as Bothnia-type PPK or keratoderma palmoplantaris diffusa, Bothnian type) is a rare inherited skin disorder characterized by diffuse thickening of the skin on the palms of the hands and soles of the feet (palmoplantar keratoderma). The condition was first described in families from the Bothnian region of northern Sweden. It is caused by mutations in the AQP5 gene, which encodes aquaporin 5, a water channel protein important for sweat gland function and skin hydration. The keratoderma typically presents in early childhood and is notable for a distinctive spongy, white appearance of the thickened skin, particularly when exposed to water or moisture (a feature sometimes described as 'transgrediens' or wet-spongy pattern). The skin thickening is generally symmetric and can cause discomfort, difficulty with manual tasks, and impaired quality of life. The condition primarily affects the integumentary system (skin), specifically the palms and soles, though the thickened skin may occasionally extend beyond these areas onto the dorsal surfaces of the hands and feet. Hyperhidrosis (excessive sweating) of the palms and soles is a commonly associated feature, which may exacerbate the spongy white appearance of the affected skin. There is no cure for Bothnian-type palmoplantar keratoderma. Treatment is symptomatic and supportive, focusing on regular use of emollients, keratolytic agents (such as urea-based or salicylic acid-based creams) to reduce skin thickness, and careful foot care to prevent secondary complications such as fungal infections. In some cases, mechanical debridement of thickened skin may be helpful. Genetic counseling is recommended for affected families.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Diffuse palmoplantar keratoderma, Bothnian type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Diffuse palmoplantar keratoderma, Bothnian type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Diffuse palmoplantar keratoderma, Bothnian type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Diffuse palmoplantar keratoderma, Bothnian type.
Community
No community posts yet. Be the first to share your experience with Diffuse palmoplantar keratoderma, Bothnian type.
Start the conversation →Latest news about Diffuse palmoplantar keratoderma, Bothnian type
No recent news articles for Diffuse palmoplantar keratoderma, Bothnian type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Diffuse palmoplantar keratoderma, Bothnian type
What is Diffuse palmoplantar keratoderma, Bothnian type?
Diffuse palmoplantar keratoderma, Bothnian type (also known as Bothnia-type PPK or keratoderma palmoplantaris diffusa, Bothnian type) is a rare inherited skin disorder characterized by diffuse thickening of the skin on the palms of the hands and soles of the feet (palmoplantar keratoderma). The condition was first described in families from the Bothnian region of northern Sweden. It is caused by mutations in the AQP5 gene, which encodes aquaporin 5, a water channel protein important for sweat gland function and skin hydration. The keratoderma typically presents in early childhood and is notabl
How is Diffuse palmoplantar keratoderma, Bothnian type inherited?
Diffuse palmoplantar keratoderma, Bothnian type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Diffuse palmoplantar keratoderma, Bothnian type typically begin?
Typical onset of Diffuse palmoplantar keratoderma, Bothnian type is childhood. Age of onset can vary across affected individuals.